ArticleOncology letters2018

High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab.

Halin Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.